We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+14.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$94.3B
AUM Growth
+$7.96B
(+9.2%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
2,315
New
140
Increased
934
Reduced
1,002
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$335M |
| 2 |
Exelon
EXC
|
+$314M |
| 3 |
Procter & Gamble
PG
|
+$241M |
| 4 |
TripAdvisor
TRIP
|
+$208M |
| 5 |
Starbucks
SBUX
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$551M |
| 2 |
Target
TGT
|
+$514M |
| 3 |
CELG
Celgene Corp
CELG
|
+$495M |
| 4 |
Cigna
CI
|
+$369M |
| 5 |
Costco
COST
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.77% |
| 2 | Healthcare | 19.09% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Industrials | 9.28% |
| 5 | Financials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Progress Software
PRGS
$1.78B
| $13.3M | 0.01% |
300,008
+6,873
| +2% | +$251K |
|
702
Emergent Biosolutions
EBS
$228M
| $13.1M | 0.01% |
259,892
-19,284
| -7% | -$1.14M |
|
703
V2X
VVX
$2.64B
| $13.1M | 0.01% |
491,809
-10,525
| -2% | -$272K |
|
704
Barrett Business Services
BBSI
$785M
| $12.9M | 0.01% |
667,892
-49,604
| -7% | -$861K |
|
705
Stride
LRN
$3.37B
| $12.9M | 0.01% |
377,345
-57,054
| -13% | -$1.74M |
|
706
CEMIG Preferred Shares
CIG
$5.89B
| $12.9M | 0.01% |
7,068,233
+1,852,480
| +36% | +$3.49M |
|
707
New Jersey Resources
NJR
$5.47B
| $12.7M | 0.01% |
254,951
+150,420
| +144% | +$7.16M |
|
|
SJR
708
DELISTED
Shaw Communications Inc.
SJR
| $12.7M | 0.01% |
609,824
-62,397
| -9% | -$1.26M |
|
709
Jacobs Solutions
J
$17.2B
| $12.7M | 0.01% |
204,064
-65,771
| -24% | -$3.7M |
|
710
Penske Automotive Group
PAG
$14.2B
| $12.6M | 0.01% |
283,155
+23,248
| +9% | +$1.03M |
|
711
STAAR Surgical
STAA
$1.25B
| $12.6M | 0.01% |
369,219
+52,831
| +17% | +$1.87M |
|
712
Lantheus
LNTH
$6.59B
| $12.6M | 0.01% |
515,284
-6,161
| -1% | -$123K |
|
713
Blackrock
BLK
$175B
| $12.4M | 0.01% |
28,946
-40,418
| -58% | -$17M |
|
714
KeyCorp
KEY
$24.3B
| $12.3M | 0.01% |
781,245
+445,846
| +133% | +$7.43M |
|
715
Qualcomm
QCOM
$172B
| $12.3M | 0.01% |
215,213
+108,181
| +101% | +$5.84M |
|
|
HIBB
716
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $12.3M | 0.01% |
537,863
+11,867
| +2% | +$209K |
|
|
EMBJ
717
Embraer S.A. ADS
EMBJ
$13.4B
| $12.3M | 0.01% |
645,170
-20,699
| -3% | -$430K |
|
718
L3Harris
LHX
$54.5B
| $12.2M | 0.01% |
76,372
-19,123
| -20% | -$2.94M |
|
719
West Pharmaceutical
WST
$25.1B
| $12.2M | 0.01% |
110,255
+44,258
| +67% | +$4.6M |
|
720
Gildan
GIL
$10.6B
| $12.1M | 0.01% |
337,602
+130,813
| +63% | +$4.47M |
|
721
Host Hotels & Resorts
HST
$15.4B
| $12.1M | 0.01% |
639,373
+38,633
| +6% | +$713K |
|
722
SEI Investments
SEIC
$12.7B
| $12.1M | 0.01% |
231,213
-115,736
| -33% | -$5.79M |
|
723
Banco de Chile
BCH
$20.9B
| $12M | 0.01% |
406,484
-51,458
| -11% | -$1.59M |
|
724
Occidental Petroleum
OXY
$58.4B
| $11.9M | 0.01% |
179,598
+57,107
| +47% | +$3.76M |
|
725
AngloGold Ashanti
AU
$48.9B
| $11.9M | 0.01% |
907,148
-1,730,697
| -66% | -$23.3M |
|
Similar funds
VGA
AQR Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, AQR Capital Management held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AQR Capital Management's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
- AQR Capital Management added most to Biogen in Q1 2019, an estimated $335M increase.
- AQR Capital Management's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
- AQR Capital Management fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
- AQR Capital Management opened 140 new positions and closed 155 in Q1 2019.
- AQR Capital Management's portfolio value rose 9.2% quarter-over-quarter to $94.3B.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.